The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis

Affiliations

• ¹ Department of Dermatology, School of Medicine, Stanford University, Palo Alto, California.
• ² Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: [email protected].
• ³ The Dermatology Center of Indiana, Plainfield, Indiana; The Indiana Clinical Trials Center, PC, Plainfield, Indiana.
• ⁴ Department of Dermatology, University of New South Wales, School of Medicine, Sydney, New South Wales, Australia.
• ⁵ Division of Dermatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
• ⁶ Associated Skin Care Specialists, New Brighton, Minnesota.
• ⁷ The Indiana Clinical Trials Center, PC, Plainfield, Indiana.
• ⁸ Timber Pharmaceuticals, Basking Ridge, New Jersey.
• ⁹ Division of Pediartics and Dermatology, University of Pennsylvania, Perelman School of Medicine and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.